View source for Chemistry:25C-NBF

{{Short description|Chemical compound}}
{{Drugbox
| verifiedrevid = 
| IUPAC_name = 
| image = 25C-NBF.svg
| width = 200px

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| routes_of_administration =  
| legal_BR = F2
| legal_DE = NpSG
| legal_UK = Class A

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 1539266-21-1
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TF5JW72ANY
| CAS_supplemental =  
| ATC_prefix = none
| PubChem = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 32055558
}}

'''25C-NBF''' ('''2C-C-NBF''', '''NBF-2C-C''') is a derivative of the [[Biology:Phenethylamine|phenethylamine]] [[Chemistry:Psychedelic drug|hallucinogen]] [[Chemistry:2C-C|2C-C]], which acts as a highly [[Chemistry:Potency (pharmacology)|potent]] [[Chemistry:Partial agonist|partial agonist]] for the [[Biology:Human|human]] [[Biology:5-HT2A receptor|5-HT<sub>2A</sub>]] [[Biology:Receptor (biochemistry)|receptor]].<ref>{{cite journal | vauthors = Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL | title = Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists | journal = ACS Chemical Neuroscience | volume = 5 | issue = 3 | pages = 243–9 | date = March 2014 | pmid = 24397362 | pmc = 3963123 | doi = 10.1021/cn400216u }}</ref><ref>{{cite thesis | vauthors = Hansen M | title = Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. | degree = Ph.D. | publisher = University of Copenhagen | date = 2010-12-16 | doi = 10.13140/RG.2.2.33671.14245}}</ref>

==Legality==

===Sweden===
The Riksdag added 25C-NBF to Narcotic Drugs Punishments Act under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of January 26, 2016, published by [[Organization:Medical Products Agency (Sweden)|Medical Products Agency (MPA)]] in regulation ''HSLF-FS 2015:35'' listed as '''25C-NBF''', and '''2-(4-kloro-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin'''.<ref>{{Cite web |url=https://lakemedelsverket.se/upload/lvfs/HSLF-FS/HSLFS-FS_2015_35.pdf |title=Archived copy |access-date=2017-04-21 |archive-date=2017-10-31 |archive-url=https://web.archive.org/web/20171031000431/https://lakemedelsverket.se/upload/lvfs/HSLF-FS/HSLFS-FS_2015_35.pdf |url-status=dead }}</ref>

===United Kingdom===
{{N-benzylphenethylamine-Legality-United Kingdom}}

==Analogues and derivatives==
{{2C-C analogues and derivatives}}

== References ==
{{Reflist}}

{{Hallucinogens}}
{{Serotonin receptor modulators}}
{{Phenethylamines}}

[[Category:Designer drugs]]

{{Sourceattribution|25C-NBF}}